Expert insights. Personalized for you.
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched MORE
108 
By March, the FDA expects to conclude reviews of key drugs for heart failure, Duchenne's and multiple myeloma, as well as decide on whether to clear Biogen's controversial Alzheimer's treatment MORE
In an unusual statement, FDA chief Stephen Hahn and top official Peter Marks opposed altering vaccination regimens without further evidence, calling proposals to do so "premature " MORE
Concept of high entropy alloys provides a discovery platform for new superconductors Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University mixed and designed a new, high entropy alloy (HEA) superconductor, using extensive data on simple superconducting substances with a specific crystal structure. MORE
KRAS mutations are found in several hard-to-treat cancers MORE
Tinkering with the dosing schedule of COVID-19 vaccines runs a “significant risk” to public health, the FDA has warned in a statement after the UK announced plans to prioritise the first doses of two approved shots. MORE
PONTIFICATION: Healthcare agencies need to be the agents of change and lead by example. Speculation or buying into the temporary changes brought on by the pandemic are unrealistic. MORE
The European Union has approved the coronavirus vaccine from Moderna, leaving the UK trailing because of changes to post-Brexit drug approval rules. MORE
Credit: Mount Sinai Health System The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research. MORE
Company executives, however, blamed "improbably bad luck" for study enrollment that resulted in more older patients with milder disease receiving placebo, and pledged to press on MORE
The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to research from the drugs giant. MORE
BioSpace spoke to executives from four companies about their expectations for the conference and the coming year MORE
Shot was approved by MHRA on 30 December MORE
The World Health Organizationâs vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations. Markets & Regulations MORE
Partnering with German biotech ViGeneron bolsters Biogen's pipeline of drugs for eye diseases, which includes assets acquired through its buyout of Nightstar Therapeutics MORE
SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. MORE
As Operation Warp Speed struggles to ramp up vaccinations, one of the approaches under consideration is cutting the doses of the Moderna vaccine MORE
The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature. MORE
With additional financing, Celularity will have $372 million to back development of experimental off-the-shelf treatments for cancer and autoimmune diseases MORE
275 
MINUTE READ: Big pharma should take a good, hard look at small biotech companies and try to better understand how they succeed and are able to make strategic decisions faster without multi-levels of bureaucracy. MORE
Grant establishes network of bee researchers at four UC campuses Credit: Boris Baer/UCR The University of California, Riverside, is leading a new effort to stop and reverse a worldwide decline in honeybees, which threatens food security and prices. MORE
Gene therapy developers will need to address a series of setbacks that have shaded optimism in the sector's fast growth MORE
Credit: C. Zhou, C. Sodhi and D. MORE
It’s not particularly surprising that there wasn’t a lot of clinical trial news between Christmas and New Year’s, although there was some. Here’s a look MORE
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. MORE
IN SUMMARY: The Democrats control the Senate now, A poll last April shows that 69 percent of registered voters support Medicare for All, a plan that would create a national health insurance plan available for all Americans. The poll was conducted by the Washington, D.C. MORE
The first patient enrolled in a Phase 3 trial of Pfizer's treatment was given the experimental one-time therapy on Dec. MORE
This news, published in the American Journal of Human Genetics, enables researchers to develop early screening methods before the most serious symptoms arise, and thus intervene MORE
Credit: University of Leeds Researchers have for the first time identified the way viruses like the poliovirus and the common cold virus ‘package up’ their genetic code, allowing them to infect cells. MORE
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. MORE
Research team determines that the “Immune only” focus of current research must be updated to better understand autoimmune diseases such as type 1 diabetes and multiple sclerosis Credit: Indiana Biosciences Research Institute Indianapolis, Ind. MORE
Bio Pharma Dive
JANUARY 5, 2021
By March, the FDA expects to conclude reviews of key drugs for heart failure, Duchenne's and multiple myeloma, as well as decide on whether to clear Biogen's controversial Alzheimer's treatment
World of DTC Marketing
JANUARY 8, 2021
SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
JANUARY 4, 2021
Welcome to the World of Hyperautomation Credit: World Scientific Two centuries ago, the Industrial Revolution began to automate “blue-collar” work, allowing higher profits and wider societal improvements like the reduction of famine and the increase in living standards.
XTalks
JANUARY 8, 2021
The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature.
Bio Pharma Dive
JANUARY 8, 2021
With additional financing, Celularity will have $372 million to back development of experimental off-the-shelf treatments for cancer and autoimmune diseases
World of DTC Marketing
JANUARY 7, 2021
MINUTE READ: Big pharma should take a good, hard look at small biotech companies and try to better understand how they succeed and are able to make strategic decisions faster without multi-levels of bureaucracy.
BioPharma Reporter
JANUARY 7, 2021
The World Health Organizationâs vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations. Markets & Regulations
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
Bio Pharma Dive
JANUARY 7, 2021
The first patient enrolled in a Phase 3 trial of Pfizer's treatment was given the experimental one-time therapy on Dec.
World of DTC Marketing
JANUARY 6, 2021
IN SUMMARY: The Democrats control the Senate now, A poll last April shows that 69 percent of registered voters support Medicare for All, a plan that would create a national health insurance plan available for all Americans. The poll was conducted by the Washington, D.C.
Scienmag
JANUARY 4, 2021
Credit: Nitzan Shabek Plants can perceive and react to light across a wide spectrum. New research from Prof. Nitzan Shabek’s laboratory in the Department of Plant Biology, College of Biological Sciences shows how plants can respond to blue light in particular.
BioSpace
JANUARY 5, 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched
Bio Pharma Dive
JANUARY 8, 2021
Gene therapy developers will need to address a series of setbacks that have shaded optimism in the sector's fast growth
World of DTC Marketing
JANUARY 4, 2021
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs.
Scienmag
JANUARY 8, 2021
Credit: University of Leeds Researchers have for the first time identified the way viruses like the poliovirus and the common cold virus ‘package up’ their genetic code, allowing them to infect cells.
BioSpace
JANUARY 3, 2021
As Operation Warp Speed struggles to ramp up vaccinations, one of the approaches under consideration is cutting the doses of the Moderna vaccine
Bio Pharma Dive
JANUARY 5, 2021
Founded by industry veteran Arie Belldegrun's venture capital firm, IconOVir Bio raised $77 million to push its lead drug — derived from the common cold — into clinical testing
World of DTC Marketing
JANUARY 6, 2021
PONTIFICATION: Healthcare agencies need to be the agents of change and lead by example. Speculation or buying into the temporary changes brought on by the pandemic are unrealistic.
Scienmag
JANUARY 7, 2021
Grant establishes network of bee researchers at four UC campuses Credit: Boris Baer/UCR The University of California, Riverside, is leading a new effort to stop and reverse a worldwide decline in honeybees, which threatens food security and prices.
BioSpace
JANUARY 3, 2021
Here’s a look at the top 10 novel drug approvals of 2020, loosely based on projected earnings in the upcoming years
Bio Pharma Dive
JANUARY 6, 2021
Partnering with German biotech ViGeneron bolsters Biogen's pipeline of drugs for eye diseases, which includes assets acquired through its buyout of Nightstar Therapeutics
Pharma Times
JANUARY 4, 2021
KRAS mutations are found in several hard-to-treat cancers
Pharma Marketing Network
JANUARY 6, 2021
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021.
Scienmag
JANUARY 8, 2021
Concept of high entropy alloys provides a discovery platform for new superconductors Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University mixed and designed a new, high entropy alloy (HEA) superconductor, using extensive data on simple superconducting substances with a specific crystal structure.
Bio Pharma Dive
JANUARY 7, 2021
Company executives, however, blamed "improbably bad luck" for study enrollment that resulted in more older patients with milder disease receiving placebo, and pledged to press on
BioSpace
JANUARY 3, 2021
It’s not particularly surprising that there wasn’t a lot of clinical trial news between Christmas and New Year’s, although there was some. Here’s a look
Pharma Phorum
JANUARY 8, 2021
The Pfizer/BioNTech vaccine appears to work against an important mutation in the new coronavirus variants causing havoc in the UK and South Africa, according to research from the drugs giant.
Scienmag
JANUARY 6, 2021
Credit: C. Zhou, C. Sodhi and D.
Bio Pharma Dive
JANUARY 4, 2021
With no decision from the FDA on approval of an experimental cancer cell therapy, an agreement by Bristol Myers to pay out more money as part of its Celgene acquisition fell apart
BioSpace
JANUARY 3, 2021
This news, published in the American Journal of Human Genetics, enables researchers to develop early screening methods before the most serious symptoms arise, and thus intervene
Pharma Phorum
JANUARY 5, 2021
Tinkering with the dosing schedule of COVID-19 vaccines runs a “significant risk” to public health, the FDA has warned in a statement after the UK announced plans to prioritise the first doses of two approved shots.
Scienmag
JANUARY 7, 2021
Credit: Mount Sinai Health System The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research.
Bio Pharma Dive
JANUARY 6, 2021
A Series B investment in Senti Biosciences will support the startup's research on off-the-shelf candidates, as Bayer places another bet on cell therapy
BioSpace
JANUARY 7, 2021
BioSpace spoke to executives from four companies about their expectations for the conference and the coming year
Pharma Times
JANUARY 4, 2021
Shot was approved by MHRA on 30 December
Scienmag
JANUARY 6, 2021
Research team determines that the “Immune only” focus of current research must be updated to better understand autoimmune diseases such as type 1 diabetes and multiple sclerosis Credit: Indiana Biosciences Research Institute Indianapolis, Ind.
Bio Pharma Dive
JANUARY 5, 2021
In an unusual statement, FDA chief Stephen Hahn and top official Peter Marks opposed altering vaccination regimens without further evidence, calling proposals to do so "premature "
BioSpace
JANUARY 3, 2021
As the sun rose on a new year, approximately 70 companies raised the price of hundreds of prescription drugs by an average of 3.3
Let's personalize your content